Global and China Amlodipine Market Insights, Forecast to 2027

Publisher Name :
Date: 20-Dec-2021
No. of pages: 160
Inquire Before Buying

Amlodipine market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Amlodipine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.

For China market, this report focuses on the Amlodipine market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in China.

Segment by Type

- by Product

- - Amlodipine Benzene Sulfonate Tablet

- - Amlodipine Mesylate Tablet

- - Levoamlodipine Maleic Acid Tablet

- by Form

- - Tablets

- - Capsule

Segment by Application

- High Blood Pressure

- Angina Pectoris

- Other

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Australia

- - Taiwan

- - Indonesia

- - Thailand

- - Malaysia

- - Philippines

- - Vietnam

- Latin America

- - Mexico

- - Brazil

- - Argentina

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

By Company

- Novartis

- Pfizer

- Lek

- TEVA

- Macleods Pharmaceuticals

- Caraco Pharmaceutical

- Sanis Health

- Jamp Pharma

- Accel Pharma

- Jubilant Generics

- Angita Pharma

- Florida DOH Central Pharmacy

- Shanghai Disainuo Biopharmaceutical

- Northeast Pharmaceutical Group Shenyang No. 1 Pharmaceutical

- Beijing Wansheng Pharmaceutical

- Beijing Honglin Pharmaceutical

- Beijing Maidihai Pharmaceutical

- China Resources Saike Pharmaceutical

- Beijing Jiulong Pharmaceutical

- Tiannian Pharmaceutical

- Chengdu Diao Pharmaceutical Group

- Yangtze Pharmaceutical

- Kunming Sino Pharmaceutical

- Wuhan Dongxin Pharmaceutical Technology

- Jiangsu Wangao Pharmaceutical

- Jiangsu Lianhuan Pharmaceutical

- Jiangsu Huanghe Pharmaceutical

- Zhejiang Jingxin Pharmaceutical

- Zhejiang Jianfeng Pharmaceutical

- Hunan Qianjinxieli Pharmaceutical

Global and China Amlodipine Market Insights, Forecast to 2027

Table of Contents
1 Study Coverage
1.1 Amlodipine Product Introduction
1.2 Market by Type
1.2.1 Global Amlodipine Market Size Growth Rate by Type
1.2.2 Amlodipine Benzene Sulfonate Tablet
1.2.3 Amlodipine Mesylate Tablet
1.2.4 Levoamlodipine Maleic Acid Tablet
1.3 Market by Application
1.3.1 Global Amlodipine Market Size Growth Rate by Application
1.3.2 High Blood Pressure
1.3.3 Angina Pectoris
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Amlodipine Market Size, Estimates and Forecasts
2.1.1 Global Amlodipine Revenue 2016-2027
2.1.2 Global Amlodipine Sales 2016-2027
2.2 Global Amlodipine, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Amlodipine Historical Market Size by Region (2016-2021)
2.3.1 Global Amlodipine Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Amlodipine Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Amlodipine Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Amlodipine Sales Forecast by Region (2022-2027)
2.4.2 Global Amlodipine Revenue Forecast by Region (2022-2027)
3 Global Amlodipine Competitor Landscape by Players
3.1 Global Top Amlodipine Manufacturers by Sales
3.1.1 Global Amlodipine Sales by Manufacturer (2016-2021)
3.1.2 Global Amlodipine Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Amlodipine Manufacturers by Revenue
3.2.1 Key Amlodipine Manufacturers Covered: Ranking by Revenue
3.2.2 Global Amlodipine Revenue by Manufacturers (2016-2021)
3.2.3 Global Amlodipine Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Amlodipine Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Amlodipine Revenue in 2020
3.2.6 Global Amlodipine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Amlodipine Price by Manufacturers
3.4 Global Amlodipine Manufacturing Base Distribution, Product Types
3.4.1 Amlodipine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Amlodipine Product Type
3.4.3 Date of International Manufacturers Enter into Amlodipine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Amlodipine Market Size by Type (2016-2021)
4.1.1 Global Amlodipine Sales by Type (2016-2021)
4.1.2 Global Amlodipine Revenue by Type (2016-2021)
4.1.3 Amlodipine Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Amlodipine Market Size Forecast by Type (2022-2027)
4.2.1 Global Amlodipine Sales Forecast by Type (2022-2027)
4.2.2 Global Amlodipine Revenue Forecast by Type (2022-2027)
4.2.3 Amlodipine Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Amlodipine Market Size by Application (2016-2021)
5.1.1 Global Amlodipine Sales by Application (2016-2021)
5.1.2 Global Amlodipine Revenue by Application (2016-2021)
5.1.3 Amlodipine Price by Application (2016-2021)
5.2 Amlodipine Market Size Forecast by Application (2022-2027)
5.2.1 Global Amlodipine Sales Forecast by Application (2022-2027)
5.2.2 Global Amlodipine Revenue Forecast by Application (2022-2027)
5.2.3 Global Amlodipine Price Forecast by Application (2022-2027)
6 China by Players, Type and Application
6.1 China Amlodipine Market Size YoY Growth 2016-2027
6.1.1 China Amlodipine Sales YoY Growth 2016-2027
6.1.2 China Amlodipine Revenue YoY Growth 2016-2027
6.1.3 China Amlodipine Market Share in Global Market 2016-2027
6.2 China Amlodipine Market Size by Players (International and Local Players)
6.2.1 China Top Amlodipine Players by Sales (2016-2021)
6.2.2 China Top Amlodipine Players by Revenue (2016-2021)
6.3 China Amlodipine Historic Market Review by Type (2016-2021)
6.3.1 China Amlodipine Sales Market Share by Type (2016-2021)
6.3.2 China Amlodipine Revenue Market Share by Type (2016-2021)
6.3.3 China Amlodipine Price by Type (2016-2021)
6.4 China Amlodipine Market Estimates and Forecasts by Type (2022-2027)
6.4.1 China Amlodipine Sales Forecast by Type (2022-2027)
6.4.2 China Amlodipine Revenue Forecast by Type (2022-2027)
6.4.3 China Amlodipine Price Forecast by Type (2022-2027)
6.5 China Amlodipine Historic Market Review by Application (2016-2021)
6.5.1 China Amlodipine Sales Market Share by Application (2016-2021)
6.5.2 China Amlodipine Revenue Market Share by Application (2016-2021)
6.5.3 China Amlodipine Price by Application (2016-2021)
6.6 China Amlodipine Market Estimates and Forecasts by Application (2022-2027)
6.6.1 China Amlodipine Sales Forecast by Application (2022-2027)
6.6.2 China Amlodipine Revenue Forecast by Application (2022-2027)
6.6.3 China Amlodipine Price Forecast by Application (2022-2027)
7 North America
7.1 North America Amlodipine Market Size YoY Growth 2016-2027
7.2 North America Amlodipine Market Facts & Figures by Country
7.2.1 North America Amlodipine Sales by Country (2016-2021)
7.2.2 North America Amlodipine Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Amlodipine Market Size YoY Growth 2016-2027
8.2 Asia Pacific Amlodipine Market Facts & Figures by Region
8.2.1 Asia Pacific Amlodipine Sales by Region (2016-2021)
8.2.2 Asia Pacific Amlodipine Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam
9 Europe
9.1 Europe Amlodipine Market Size YoY Growth 2016-2027
9.2 Europe Amlodipine Market Facts & Figures by Country
9.2.1 Europe Amlodipine Sales by Country (2016-2021)
9.2.2 Europe Amlodipine Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Amlodipine Market Size YoY Growth 2016-2027
10.2 Latin America Amlodipine Market Facts & Figures by Country
10.2.1 Latin America Amlodipine Sales by Country (2016-2021)
10.2.2 Latin America Amlodipine Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Amlodipine Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Amlodipine Market Facts & Figures by Country
11.2.1 Middle East and Africa Amlodipine Sales by Country (2016-2021)
11.2.2 Middle East and Africa Amlodipine Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 UAE
12 Company Profiles
12.1 Novartis
12.1.1 Novartis Corporation Information
12.1.2 Novartis Description and Business Overview
12.1.3 Novartis Amlodipine Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Novartis Amlodipine Products Offered
12.1.5 Novartis Recent Development
12.2 Pfizer
12.2.1 Pfizer Corporation Information
12.2.2 Pfizer Description and Business Overview
12.2.3 Pfizer Amlodipine Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Pfizer Amlodipine Products Offered
12.2.5 Pfizer Recent Development
12.3 Lek
12.3.1 Lek Corporation Information
12.3.2 Lek Description and Business Overview
12.3.3 Lek Amlodipine Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Lek Amlodipine Products Offered
12.3.5 Lek Recent Development
12.4 TEVA
12.4.1 TEVA Corporation Information
12.4.2 TEVA Description and Business Overview
12.4.3 TEVA Amlodipine Sales, Revenue and Gross Margin (2016-2021)
12.4.4 TEVA Amlodipine Products Offered
12.4.5 TEVA Recent Development
12.5 Macleods Pharmaceuticals
12.5.1 Macleods Pharmaceuticals Corporation Information
12.5.2 Macleods Pharmaceuticals Description and Business Overview
12.5.3 Macleods Pharmaceuticals Amlodipine Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Macleods Pharmaceuticals Amlodipine Products Offered
12.5.5 Macleods Pharmaceuticals Recent Development
12.6 Caraco Pharmaceutical
12.6.1 Caraco Pharmaceutical Corporation Information
12.6.2 Caraco Pharmaceutical Description and Business Overview
12.6.3 Caraco Pharmaceutical Amlodipine Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Caraco Pharmaceutical Amlodipine Products Offered
12.6.5 Caraco Pharmaceutical Recent Development
12.7 Sanis Health
12.7.1 Sanis Health Corporation Information
12.7.2 Sanis Health Description and Business Overview
12.7.3 Sanis Health Amlodipine Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Sanis Health Amlodipine Products Offered
12.7.5 Sanis Health Recent Development
12.8 Jamp Pharma
12.8.1 Jamp Pharma Corporation Information
12.8.2 Jamp Pharma Description and Business Overview
12.8.3 Jamp Pharma Amlodipine Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Jamp Pharma Amlodipine Products Offered
12.8.5 Jamp Pharma Recent Development
12.9 Accel Pharma
12.9.1 Accel Pharma Corporation Information
12.9.2 Accel Pharma Description and Business Overview
12.9.3 Accel Pharma Amlodipine Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Accel Pharma Amlodipine Products Offered
12.9.5 Accel Pharma Recent Development
12.10 Jubilant Generics
12.10.1 Jubilant Generics Corporation Information
12.10.2 Jubilant Generics Description and Business Overview
12.10.3 Jubilant Generics Amlodipine Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Jubilant Generics Amlodipine Products Offered
12.10.5 Jubilant Generics Recent Development
12.11 Novartis
12.11.1 Novartis Corporation Information
12.11.2 Novartis Description and Business Overview
12.11.3 Novartis Amlodipine Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Novartis Amlodipine Products Offered
12.11.5 Novartis Recent Development
12.12 Florida DOH Central Pharmacy
12.12.1 Florida DOH Central Pharmacy Corporation Information
12.12.2 Florida DOH Central Pharmacy Description and Business Overview
12.12.3 Florida DOH Central Pharmacy Amlodipine Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Florida DOH Central Pharmacy Products Offered
12.12.5 Florida DOH Central Pharmacy Recent Development
12.13 Shanghai Disainuo Biopharmaceutical
12.13.1 Shanghai Disainuo Biopharmaceutical Corporation Information
12.13.2 Shanghai Disainuo Biopharmaceutical Description and Business Overview
12.13.3 Shanghai Disainuo Biopharmaceutical Amlodipine Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Shanghai Disainuo Biopharmaceutical Products Offered
12.13.5 Shanghai Disainuo Biopharmaceutical Recent Development
12.14 Northeast Pharmaceutical Group Shenyang No. 1 Pharmaceutical
12.14.1 Northeast Pharmaceutical Group Shenyang No. 1 Pharmaceutical Corporation Information
12.14.2 Northeast Pharmaceutical Group Shenyang No. 1 Pharmaceutical Description and Business Overview
12.14.3 Northeast Pharmaceutical Group Shenyang No. 1 Pharmaceutical Amlodipine Sales, Revenue and Gross Margin (2016-2021)
12.14.4 Northeast Pharmaceutical Group Shenyang No. 1 Pharmaceutical Products Offered
12.14.5 Northeast Pharmaceutical Group Shenyang No. 1 Pharmaceutical Recent Development
12.15 Beijing Wansheng Pharmaceutical
12.15.1 Beijing Wansheng Pharmaceutical Corporation Information
12.15.2 Beijing Wansheng Pharmaceutical Description and Business Overview
12.15.3 Beijing Wansheng Pharmaceutical Amlodipine Sales, Revenue and Gross Margin (2016-2021)
12.15.4 Beijing Wansheng Pharmaceutical Products Offered
12.15.5 Beijing Wansheng Pharmaceutical Recent Development
12.16 Beijing Honglin Pharmaceutical
12.16.1 Beijing Honglin Pharmaceutical Corporation Information
12.16.2 Beijing Honglin Pharmaceutical Description and Business Overview
12.16.3 Beijing Honglin Pharmaceutical Amlodipine Sales, Revenue and Gross Margin (2016-2021)
12.16.4 Beijing Honglin Pharmaceutical Products Offered
12.16.5 Beijing Honglin Pharmaceutical Recent Development
12.17 Beijing Maidihai Pharmaceutical
12.17.1 Beijing Maidihai Pharmaceutical Corporation Information
12.17.2 Beijing Maidihai Pharmaceutical Description and Business Overview
12.17.3 Beijing Maidihai Pharmaceutical Amlodipine Sales, Revenue and Gross Margin (2016-2021)
12.17.4 Beijing Maidihai Pharmaceutical Products Offered
12.17.5 Beijing Maidihai Pharmaceutical Recent Development
12.18 China Resources Saike Pharmaceutical
12.18.1 China Resources Saike Pharmaceutical Corporation Information
12.18.2 China Resources Saike Pharmaceutical Description and Business Overview
12.18.3 China Resources Saike Pharmaceutical Amlodipine Sales, Revenue and Gross Margin (2016-2021)
12.18.4 China Resources Saike Pharmaceutical Products Offered
12.18.5 China Resources Saike Pharmaceutical Recent Development
12.19 Beijing Jiulong Pharmaceutical
12.19.1 Beijing Jiulong Pharmaceutical Corporation Information
12.19.2 Beijing Jiulong Pharmaceutical Description and Business Overview
12.19.3 Beijing Jiulong Pharmaceutical Amlodipine Sales, Revenue and Gross Margin (2016-2021)
12.19.4 Beijing Jiulong Pharmaceutical Products Offered
12.19.5 Beijing Jiulong Pharmaceutical Recent Development
12.20 Tiannian Pharmaceutical
12.20.1 Tiannian Pharmaceutical Corporation Information
12.20.2 Tiannian Pharmaceutical Description and Business Overview
12.20.3 Tiannian Pharmaceutical Amlodipine Sales, Revenue and Gross Margin (2016-2021)
12.20.4 Tiannian Pharmaceutical Products Offered
12.20.5 Tiannian Pharmaceutical Recent Development
12.21 Chengdu Diao Pharmaceutical Group
12.21.1 Chengdu Diao Pharmaceutical Group Corporation Information
12.21.2 Chengdu Diao Pharmaceutical Group Description and Business Overview
12.21.3 Chengdu Diao Pharmaceutical Group Amlodipine Sales, Revenue and Gross Margin (2016-2021)
12.21.4 Chengdu Diao Pharmaceutical Group Products Offered
12.21.5 Chengdu Diao Pharmaceutical Group Recent Development
12.22 Yangtze Pharmaceutical
12.22.1 Yangtze Pharmaceutical Corporation Information
12.22.2 Yangtze Pharmaceutical Description and Business Overview
12.22.3 Yangtze Pharmaceutical Amlodipine Sales, Revenue and Gross Margin (2016-2021)
12.22.4 Yangtze Pharmaceutical Products Offered
12.22.5 Yangtze Pharmaceutical Recent Development
12.23 Kunming Sino Pharmaceutical
12.23.1 Kunming Sino Pharmaceutical Corporation Information
12.23.2 Kunming Sino Pharmaceutical Description and Business Overview
12.23.3 Kunming Sino Pharmaceutical Amlodipine Sales, Revenue and Gross Margin (2016-2021)
12.23.4 Kunming Sino Pharmaceutical Products Offered
12.23.5 Kunming Sino Pharmaceutical Recent Development
12.24 Wuhan Dongxin Pharmaceutical Technology
12.24.1 Wuhan Dongxin Pharmaceutical Technology Corporation Information
12.24.2 Wuhan Dongxin Pharmaceutical Technology Description and Business Overview
12.24.3 Wuhan Dongxin Pharmaceutical Technology Amlodipine Sales, Revenue and Gross Margin (2016-2021)
12.24.4 Wuhan Dongxin Pharmaceutical Technology Products Offered
12.24.5 Wuhan Dongxin Pharmaceutical Technology Recent Development
12.25 Jiangsu Wangao Pharmaceutical
12.25.1 Jiangsu Wangao Pharmaceutical Corporation Information
12.25.2 Jiangsu Wangao Pharmaceutical Description and Business Overview
12.25.3 Jiangsu Wangao Pharmaceutical Amlodipine Sales, Revenue and Gross Margin (2016-2021)
12.25.4 Jiangsu Wangao Pharmaceutical Products Offered
12.25.5 Jiangsu Wangao Pharmaceutical Recent Development
12.26 Jiangsu Lianhuan Pharmaceutical
12.26.1 Jiangsu Lianhuan Pharmaceutical Corporation Information
12.26.2 Jiangsu Lianhuan Pharmaceutical Description and Business Overview
12.26.3 Jiangsu Lianhuan Pharmaceutical Amlodipine Sales, Revenue and Gross Margin (2016-2021)
12.26.4 Jiangsu Lianhuan Pharmaceutical Products Offered
12.26.5 Jiangsu Lianhuan Pharmaceutical Recent Development
12.27 Jiangsu Huanghe Pharmaceutical
12.27.1 Jiangsu Huanghe Pharmaceutical Corporation Information
12.27.2 Jiangsu Huanghe Pharmaceutical Description and Business Overview
12.27.3 Jiangsu Huanghe Pharmaceutical Amlodipine Sales, Revenue and Gross Margin (2016-2021)
12.27.4 Jiangsu Huanghe Pharmaceutical Products Offered
12.27.5 Jiangsu Huanghe Pharmaceutical Recent Development
12.28 Zhejiang Jingxin Pharmaceutical
12.28.1 Zhejiang Jingxin Pharmaceutical Corporation Information
12.28.2 Zhejiang Jingxin Pharmaceutical Description and Business Overview
12.28.3 Zhejiang Jingxin Pharmaceutical Amlodipine Sales, Revenue and Gross Margin (2016-2021)
12.28.4 Zhejiang Jingxin Pharmaceutical Products Offered
12.28.5 Zhejiang Jingxin Pharmaceutical Recent Development
12.29 Zhejiang Jianfeng Pharmaceutical
12.29.1 Zhejiang Jianfeng Pharmaceutical Corporation Information
12.29.2 Zhejiang Jianfeng Pharmaceutical Description and Business Overview
12.29.3 Zhejiang Jianfeng Pharmaceutical Amlodipine Sales, Revenue and Gross Margin (2016-2021)
12.29.4 Zhejiang Jianfeng Pharmaceutical Products Offered
12.29.5 Zhejiang Jianfeng Pharmaceutical Recent Development
12.30 Hunan Qianjinxieli Pharmaceutical
12.30.1 Hunan Qianjinxieli Pharmaceutical Corporation Information
12.30.2 Hunan Qianjinxieli Pharmaceutical Description and Business Overview
12.30.3 Hunan Qianjinxieli Pharmaceutical Amlodipine Sales, Revenue and Gross Margin (2016-2021)
12.30.4 Hunan Qianjinxieli Pharmaceutical Products Offered
12.30.5 Hunan Qianjinxieli Pharmaceutical Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Amlodipine Industry Trends
13.2 Amlodipine Market Drivers
13.3 Amlodipine Market Challenges
13.4 Amlodipine Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Amlodipine Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables
Table 1. Global Amlodipine Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Amlodipine Benzene Sulfonate Tablet
Table 3. Major Manufacturers of Amlodipine Mesylate Tablet
Table 4. Major Manufacturers of Levoamlodipine Maleic Acid Tablet
Table 5. Global Amlodipine Market Size Growth Rate by Application (2021-2027) & (KG)
Table 6. Global Amlodipine Market Size by Region (KG) & (US$ Million), 2016 VS 2021 VS 2027
Table 7. Global Amlodipine Sales by Regions (2016-2021) & (KG)
Table 8. Global Amlodipine Sales Market Share by Regions (2016-2021)
Table 9. Global Amlodipine Revenue by Regions (2016-2021) & (US$ Million)
Table 10. Global Amlodipine Sales Forecast by Region (2022-2027) & (KG)
Table 11. Global Amlodipine Sales Market Share Forecast by Region (2022-2027)
Table 12. Global Amlodipine Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 13. Global Amlodipine Revenue Market Share Forecast by Region (2022-2027)
Table 14. Global Amlodipine Sales by Manufacturers (2016-2021) (KG)
Table 15. Global Amlodipine Sales Share by Manufacturers (2016-2021)
Table 16. Ranking of Global Top Amlodipine Manufacturers by Revenue (US$ Million) in 2020
Table 17. Amlodipine Revenue by Manufacturers (2016-2021) (US$ Million)
Table 18. Amlodipine Revenue Share by Manufacturers (2016-2021)
Table 19. Global Amlodipine Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 20. Global Amlodipine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Amlodipine as of 2020)
Table 21. Key Manufacturers Amlodipine Price (2016-2021) (US$/G)
Table 22. Amlodipine Manufacturers Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Amlodipine Product Type
Table 24. Date of International Manufacturers Enter into Amlodipine Market
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Global Amlodipine Sales by Type (2016-2021) (KG)
Table 27. Global Amlodipine Sales Share by Type (2016-2021)
Table 28. Global Amlodipine Revenue by Type (2016-2021) (US$ Million)
Table 29. Global Amlodipine Revenue Share by Type (2016-2021)
Table 30. Amlodipine Average Selling Price (ASP) by Type (2016-2021) & (US$/G)
Table 31. Global Amlodipine Sales Forecast by Type (2022-2027) & (KG)
Table 32. Global Amlodipine Sales Market Share Forecast by Type (2022-2027)
Table 33. Global Amlodipine Revenue Forecast V (2022-2027) & (US$ Million)
Table 34. Global Amlodipine Revenue Market Share Forecast by Type (2022-2027)
Table 35. Global Amlodipine Average Selling Price (ASP) Forecast by Type (2022-2027) & (US$/G)
Table 36. Global Amlodipine Sales by Application (2016-2021) (KG)
Table 37. Global Amlodipine Sales Share by Application (2016-2021)
Table 38. Global Amlodipine Revenue by Application (2016-2021) (US$ Million)
Table 39. Global Amlodipine Revenue Share by Application (2016-2021)
Table 40. Amlodipine Average Selling Price (ASP) by Application (2016-2021) & (US$/G)
Table 41. Global Amlodipine Sales Forecast by Application (2022-2027) & (KG)
Table 42. Global Amlodipine Sales Market Share Forecast by Application (2022-2027)
Table 43. Global Amlodipine Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 44. Global Amlodipine Revenue Market Share Forecast by Application (2022-2027)
Table 45. Global Amlodipine Average Selling Price (ASP) Forecast by Application (2022-2027) & (US$/G)
Table 46. China Amlodipine Sales (KG) of Key Companies (2016-2021)
Table 47. China Amlodipine Sales Share by Company (2016-2021)
Table 48. China Amlodipine Revenue (US$ Million) by Company (2016-2021)
Table 49. China Amlodipine Revenue Share by Company (2016-2021)
Table 50. China Amlodipine Sales (KG) by Type (2016-2021)
Table 51. China Amlodipine Sales Share by Type (2016-2021)
Table 52. China Amlodipine Revenue (US$ Million) Market Share by Type (2016-2021)
Table 53. China Amlodipine Price (US$/G) by Type (2016-2021)
Table 54. China Amlodipine Sales (KG) by Type (2022-2027)
Table 55. China Amlodipine Sales Share by Type (2022-2027)
Table 56. China Amlodipine Revenue (US$ Million) Market Share by Type (2022-2027)
Table 57. China Amlodipine Revenue Share by Type (2022-2027)
Table 58. China Amlodipine Price (US$/G) by Type (2022-2027)
Table 59. China Amlodipine Sales (KG) by Application (2016-2021)
Table 60. China Amlodipine Sales Share by Application (2016-2021)
Table 61. China Amlodipine Revenue (US$ Million) Market Share by Application (2016-2021)
Table 62. China Amlodipine Price (US$/G) by Application (2016-2021)
Table 63. China Amlodipine Sales (KG) by Application (2022-2027)
Table 64. China Amlodipine Sales Share by Application (2022-2027)
Table 65. China Amlodipine Revenue (US$ Million) Market Share by Application (2022-2027)
Table 66. China Amlodipine Revenue Share by Application (2022-2027)
Table 67. China Amlodipine Price (US$/G) by Application (2022-2027)
Table 68. North America Amlodipine Sales by Country (2016-2021) & (KG)
Table 69. North America Amlodipine Sales Market Share by Country (2016-2021)
Table 70. North America Amlodipine Revenue by Country (2016-2021) & (US$ Million)
Table 71. North America Amlodipine Revenue Market Share by Country (2016-2021)
Table 72. Asia Pacific Amlodipine Sales by Region (2016-2021) & (KG)
Table 73. Asia Pacific Amlodipine Sales Market Share by Region (2016-2021)
Table 74. Asia Pacific Amlodipine Revenue by Region (2016-2021) & (US$ Million)
Table 75. Asia Pacific Amlodipine Revenue Market Share by Region (2016-2021)
Table 76. Europe Amlodipine Sales by Country (2016-2021) & (KG)
Table 77. Europe Amlodipine Sales Market Share by Country (2016-2021)
Table 78. Europe Amlodipine Revenue by Country (2016-2021) & (US$ Million)
Table 79. Europe Amlodipine Revenue Market Share by Country (2016-2021)
Table 80. Latin America Amlodipine Sales by Country (2016-2021) & (KG)
Table 81. Latin America Amlodipine Sales Market Share by Country (2016-2021)
Table 82. Latin Americaa Amlodipine Revenue by Country (2016-2021) & (US$ Million)
Table 83. Latin America Amlodipine Revenue Market Share by Country (2016-2021)
Table 84. Middle East and Africa Amlodipine Sales by Country (2016-2021) & (KG)
Table 85. Middle East and Africa Amlodipine Sales Market Share by Country (2016-2021)
Table 86. Middle East and Africa Amlodipine Revenue by Country (2016-2021) & (US$ Million)
Table 87. Middle East and Africa Amlodipine Revenue Market Share by Country (2016-2021)
Table 88. Novartis Corporation Information
Table 89. Novartis Description and Business Overview
Table 90. Novartis Amlodipine Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2016-2021)
Table 91. Novartis Amlodipine Product
Table 92. Novartis Recent Development
Table 93. Pfizer Corporation Information
Table 94. Pfizer Description and Business Overview
Table 95. Pfizer Amlodipine Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2016-2021)
Table 96. Pfizer Product
Table 97. Pfizer Recent Development
Table 98. Lek Corporation Information
Table 99. Lek Description and Business Overview
Table 100. Lek Amlodipine Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2016-2021)
Table 101. Lek Product
Table 102. Lek Recent Development
Table 103. TEVA Corporation Information
Table 104. TEVA Description and Business Overview
Table 105. TEVA Amlodipine Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2016-2021)
Table 106. TEVA Product
Table 107. TEVA Recent Development
Table 108. Macleods Pharmaceuticals Corporation Information
Table 109. Macleods Pharmaceuticals Description and Business Overview
Table 110. Macleods Pharmaceuticals Amlodipine Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2016-2021)
Table 111. Macleods Pharmaceuticals Product
Table 112. Macleods Pharmaceuticals Recent Development
Table 113. Caraco Pharmaceutical Corporation Information
Table 114. Caraco Pharmaceutical Description and Business Overview
Table 115. Caraco Pharmaceutical Amlodipine Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2016-2021)
Table 116. Caraco Pharmaceutical Product
Table 117. Caraco Pharmaceutical Recent Development
Table 118. Sanis Health Corporation Information
Table 119. Sanis Health Description and Business Overview
Table 120. Sanis Health Amlodipine Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2016-2021)
Table 121. Sanis Health Product
Table 122. Sanis Health Recent Development
Table 123. Jamp Pharma Corporation Information
Table 124. Jamp Pharma Description and Business Overview
Table 125. Jamp Pharma Amlodipine Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2016-2021)
Table 126. Jamp Pharma Product
Table 127. Jamp Pharma Recent Development
Table 128. Accel Pharma Corporation Information
Table 129. Accel Pharma Description and Business Overview
Table 130. Accel Pharma Amlodipine Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2016-2021)
Table 131. Accel Pharma Product
Table 132. Accel Pharma Recent Development
Table 133. Jubilant Generics Corporation Information
Table 134. Jubilant Generics Description and Business Overview
Table 135. Jubilant Generics Amlodipine Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2016-2021)
Table 136. Jubilant Generics Product
Table 137. Jubilant Generics Recent Development
Table 138. Angita Pharma Corporation Information
Table 139. Angita Pharma Description and Business Overview
Table 140. Angita Pharma Amlodipine Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2016-2021)
Table 141. Angita Pharma Product
Table 142. Angita Pharma Recent Development
Table 143. Florida DOH Central Pharmacy Corporation Information
Table 144. Florida DOH Central Pharmacy Description and Business Overview
Table 145. Florida DOH Central Pharmacy Amlodipine Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2016-2021)
Table 146. Florida DOH Central Pharmacy Product
Table 147. Florida DOH Central Pharmacy Recent Development
Table 148. Shanghai Disainuo Biopharmaceutical Corporation Information
Table 149. Shanghai Disainuo Biopharmaceutical Description and Business Overview
Table 150. Shanghai Disainuo Biopharmaceutical Amlodipine Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2016-2021)
Table 151. Shanghai Disainuo Biopharmaceutical Product
Table 152. Shanghai Disainuo Biopharmaceutical Recent Development
Table 153. Northeast Pharmaceutical Group Shenyang No. 1 Pharmaceutical Corporation Information
Table 154. Northeast Pharmaceutical Group Shenyang No. 1 Pharmaceutical Description and Business Overview
Table 155. Northeast Pharmaceutical Group Shenyang No. 1 Pharmaceutical Amlodipine Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2016-2021)
Table 156. Northeast Pharmaceutical Group Shenyang No. 1 Pharmaceutical Product
Table 157. Northeast Pharmaceutical Group Shenyang No. 1 Pharmaceutical Recent Development
Table 158. Beijing Wansheng Pharmaceutical Corporation Information
Table 159. Beijing Wansheng Pharmaceutical Description and Business Overview
Table 160. Beijing Wansheng Pharmaceutical Amlodipine Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2016-2021)
Table 161. Beijing Wansheng Pharmaceutical Product
Table 162. Beijing Wansheng Pharmaceutical Recent Development
Table 163. Beijing Honglin Pharmaceutical Corporation Information
Table 164. Beijing Honglin Pharmaceutical Description and Business Overview
Table 165. Beijing Honglin Pharmaceutical Amlodipine Sales (KG), Revenue (US$ Million), Price (US$/G) and Gross Margin (2016-2021)
Table 166. Beijing Honglin Pharmaceutical Product
Table 167. Beijing Honglin Pharmaceutical Recent Development
Table 168. Beijing Maidihai Pharmaceutical Corporation Information
Table 169. Beijing Maidihai Pharmaceutic
  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs